Trials / Completed
CompletedNCT04839913
Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Unicentric, Regional Study
Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Update From an Unicentric, Regional Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 121 (actual)
- Sponsor
- University of Cagliari · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigator analyzed the data of the patients admitted to the surgical department during the period 1St September - 10Th December 2020 to estimate the seroprevalence of SARS-CoV-2 infection in the setting of a non-dedicated COVID-19 hospital and in a mild CoV-2 incidence area and to evaluate the difference of seroprevalence between Spring and Fall seasons in a cohort of patients undergoing surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Antibodies testing | Serologic test for both SARS-COV-2 IgG and IgM |
Timeline
- Start date
- 2020-09-01
- Primary completion
- 2020-12-10
- Completion
- 2021-01-10
- First posted
- 2021-04-09
- Last updated
- 2021-04-09
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04839913. Inclusion in this directory is not an endorsement.